Tourette Syndrome Clinical Trial
Official title:
Brain Stimulation in Movement Disorders
Brain stimulation in movement disorders
This trial will explore the effects of very gentle electrical stimulation of the brain in
patients with movement disorders. Other studies have already been carried out and have shown
that brain stimulation may help to improve mental abilities and the symptoms of conditions
such as depression and stroke. The investigators will show whether this method can help with
symptoms such as memory and concentration problems in patients with movement disorder who
have mild to moderate problems with these mental abilities. The investigators will also look
at the effects of brain stimulation on movement symptoms and mood. These people will be
compared to healthy people to help us understand whether brain stimulation works differently
in healthy people and people with brain disorders.
This trial is being carried out at one centre in Birmingham. It is scheduled to begin in
September 2014 and will last for up to five years. As the study commences it is being funded
by Birmingham and Solihull Mental Health Foundation Trust and University of Birmingham. The
investigators plan to recruit up to a maximum of 200 individuals in this study.
The procedure does not involve any surgery or hair removal. We simply put a small amount of
electrode gel on your head and then hold two electrodes on the top of your head for a short
period of time (15-20 minutes) while they generate a small electrical current. It is quite
common for participants to feel a tingling or an itch near where the electrode is applied,
but if so, this usually wears off within a few minutes. Previous research has shown this
method can occasionally lead to mild side-effects (e.g. headache, nausea, fatigue,
exacerbation of scalp skin conditions). However, there are no known harmful long term
effects. The positive benefits of brain stimulation can include improving the functioning of
the brain for a short while after the stimulation session, in a way that may help with things
like memory problems. Some people may not notice any change, but an improvement may still be
detected using tests of complex mental skills including memory tasks. It is also possible
that mood symptoms (e.g. depressive thoughts) could improve. The study will explore these
possibilities. Looking at whether brain stimulation can help with health symptoms can help us
develop new treatments.
This trial will include patients with two different movement disorders: Tourette syndrome and
Huntington's disease. In both of these conditions, changes deep within the brain can have a
knock on effect on higher brain areas important for complex mental abilities, as well as
brain areas involved in movement control. Participants will be male and female adults (aged
18-65). Patients will have either Tourette syndrome (as diagnosed according to current
medical criteria) or Huntington's disease (diagnosed by a genetic test). Patients will have
few (if any) signs of additional medical conditions. Healthy controls (who will be compared
to patients) will have no current significant medical or psychiatric diagnoses, history of
drug use or brain injury.
There will be least two separate appointments for you to attend the study center. We will
first assess your mental abilities (e.g. memory, attention) and interview you about current
mood or medical symptoms. Brain stimulation will be given to slightly different areas of the
outer part of the brain, near the top and front of the head, for each patient group. You may
be asked to take part in the trial where there is a no-treatment placebo condition, where the
procedure will feel similar to real brain stimulation, but real brain stimulation will not
take place. If you receive the placebo condition you will also receive real stimulation, but
you will not know which condition is which. This means the effects of expectations are less
likely to influence the results. After brain stimulation we will take measures of mental
abilities, and compare them to measures taken before brain stimulation, to show whether brain
stimulation has had a greater effect on mental abilities than expected by chance.
You may be asked to complete a simple task (e.g. remembering numbers) while having the brain
stimulation, as it has been suggested that this could make the effects of stimulation more
effective in improving mental skills. As the trial continues, some participants will be
invited to have repeated sessions of stimulation over a few days (e.g. three appointments
over three days in a row) to look at whether this could make the effects last longer. We will
record the effects of brain stimulation on participant's mental skills, movement symptoms and
mood, as well as any side effects. We will collect data about your symptoms and health
conditions in order to look for relationships between these factors and the effects of brain
stimulation. Finally, you may be asked to have a brain scan straight after receiving brain
stimulation, so we can look for any changes in brain activity.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04851678 -
Longitudinal Impact of Stressors in Adults With Tourette Syndrome
|
||
Completed |
NCT02605902 -
Trial to Demonstrate the Efficacy and Safety of Internet-delivered Behavioral Treatment for Adults With Tic Disorders
|
N/A | |
Completed |
NCT04007913 -
Incorporating teleCBIT Into a Hospital-Based Tic Program
|
N/A | |
Completed |
NCT02900144 -
Modified Comprehensive Behavioral Intervention for Tics (M_CBIT)
|
N/A | |
Completed |
NCT02256475 -
Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
|
Phase 1 | |
Completed |
NCT01329198 -
Brain Stimulation for the Treatment of Tourette Syndrome
|
N/A | |
Terminated |
NCT00952601 -
Pilot Study of the Modified Atkins Diet for Tourette Syndrome
|
Phase 1 | |
Enrolling by invitation |
NCT00355927 -
Sedation During Microelectrode Recordings Before Deep Brain Stimulation for Movement Disorders.
|
N/A | |
Completed |
NCT00206323 -
A Randomized, Placebo-controlled, Tourette Syndrome Study.
|
Phase 3 | |
Completed |
NCT00004376 -
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine for Tourette Syndrome and Attention Deficit Hyperactivity Disorder
|
Phase 3 | |
Completed |
NCT04498364 -
Extinction Learning in Adults With Tourette Syndrome
|
N/A | |
Completed |
NCT00755339 -
Role of the Sensory Experience in Generating Motor Tics in Tourette Syndrome
|
||
Completed |
NCT03325010 -
Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome
|
Phase 2 | |
Not yet recruiting |
NCT06081348 -
Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders
|
Phase 2 | |
Completed |
NCT01702077 -
Neurofeedback for Tourette Syndrome
|
N/A | |
Completed |
NCT01719523 -
Open-Trial of EPI-743 for Adults With Tourette Syndrome
|
Phase 1 | |
Completed |
NCT00231985 -
Effectiveness of Behavior Therapy and Psychosocial Therapy for the Treatment of Tourette Syndrome and Chronic Tic Disorder
|
Phase 2 | |
Completed |
NCT00206336 -
An Open-label Study to Determine the Efficacy and Safety of Topiramate in the Treatment of Tourette Syndrome.
|
Phase 3 | |
Terminated |
NCT03732534 -
Rollover Study for Continuing NBI-98854 Administration in Pediatric Subjects With Tourette Syndrome
|
Phase 2 | |
Completed |
NCT03625453 -
Study of ABX-1431 in Adult Patients With Tourette Syndrome or Chronic Motor Tic Disorder
|
Phase 2 |